{"id":1732,"date":"2019-12-19T16:30:45","date_gmt":"2019-12-19T21:30:45","guid":{"rendered":"https:\/\/bridgebioprod.wpengine.com\/?p=1732"},"modified":"2022-06-23T10:54:59","modified_gmt":"2022-06-23T14:54:59","slug":"bridgebio-pharma-inc-to-present-at-upcoming-investor-conference","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/","title":{"rendered":"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference"},"content":{"rendered":"\r\n<p>PALO ALTO, Calif., December 19, 2019 &#8211; BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that it will present at the 38<sup>th<\/sup> Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.<\/p>\r\n\r\n\r\n\r\n<p>The presentation will be webcast live and can be accessed at <a href=\"http:\/\/bridgebio.com\/\">www.bridgebiodev.wpengine.com<\/a> on the <em>For Investors<\/em> page under <em>News &amp; Events.<\/em> The webcast will be available for replay for 30 days.<\/p>\r\n\r\n\r\n\r\n<p><strong>About BridgeBio Pharma<\/strong><\/p>\r\n\r\n\r\n\r\n<p>BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio&#8217;s pipeline of over 15 development programs includes product candidates ranging from early discovery to late-stage development. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dTA5CXWXUTIBZPT7DkFFseeJ6dFWUH8wygANqpbpFZfifCcyLipkWa0_-UvNXXiTshA21TOAJvTy0mx6f9ifiA==\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>www.bridgebiodev.wpengine.com<\/strong><\/a>.<\/p>\r\n\r\n\r\n\r\n<p>Investor contact: <br \/>BridgeBio Pharma, Inc. <br \/><a href=\"mailto:ir@bridgebiodev.wpengine.com\">ir@bridgebiodev.wpengine.com<\/a><\/p>\r\n\r\n\r\n\r\n<p>Media contact: <br \/>BridgeBio Pharma, Inc. <br \/>Grace Rauh <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EWYCdvqfLyG_K0QTU2AJ2sVtp8YY-vj_5HmQai_GaHEwIGjMDu5y6Rtb4hDeKquHMN06Th-qe0lIbxII6KhoNzkfAWEaTG27GijiYWds_QM=\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Grace.rauh@bridgebiodev.wpengine.com<\/strong><\/a><br \/>(917) 232-5478<\/p>\r\n\r\n\r\n\r\n<p>Source: BridgeBio Pharma, Inc.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., December 19, 2019 &#8211; BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco. The presentation will be webcast live and can be accessed at www.bridgebiodev.wpengine.com on the For Investors page [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-1732","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":{"external_link":"","presentation":"","meta_short_title":"BridgeBio To Present At Upcoming Investor Conference","meta_description":"","meta_share_image":false,"people":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Investor Conference | 1\/13\/20 | BridgeBio<\/title>\n<meta name=\"description\" content=\"BridgeBio announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investor Conference | 1\/13\/20 | BridgeBio\" \/>\n<meta property=\"og:description\" content=\"BridgeBio announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-19T21:30:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-23T14:54:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Brandon Keller\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brandon Keller\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/\",\"url\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/\",\"name\":\"Investor Conference | 1\/13\/20 | BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2019-12-19T21:30:45+00:00\",\"dateModified\":\"2022-06-23T14:54:59+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325\"},\"description\":\"BridgeBio announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325\",\"name\":\"Brandon Keller\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g\",\"caption\":\"Brandon Keller\"},\"url\":\"https:\/\/bridgebio.com\/author\/bkeller\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investor Conference | 1\/13\/20 | BridgeBio","description":"BridgeBio announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Investor Conference | 1\/13\/20 | BridgeBio","og_description":"BridgeBio announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.","og_url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/","og_site_name":"BridgeBio","article_published_time":"2019-12-19T21:30:45+00:00","article_modified_time":"2022-06-23T14:54:59+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Brandon Keller","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Brandon Keller","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/","url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/","name":"Investor Conference | 1\/13\/20 | BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2019-12-19T21:30:45+00:00","dateModified":"2022-06-23T14:54:59+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325"},"description":"BridgeBio announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 3 PM (PST) in San Francisco.","breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325","name":"Brandon Keller","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g","caption":"Brandon Keller"},"url":"https:\/\/bridgebio.com\/author\/bkeller\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/1732"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=1732"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/1732\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=1732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=1732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=1732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}